Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Diogo Oliveira-Maciel"'
Autor:
Júlio Souza dos-Santos, Luan Firmino-Cruz, Alessandra Marcia da Fonseca-Martins, Diogo Oliveira-Maciel, Gustavo Guadagnini Perez, Victor A. Roncaglia-Pereira, Carlos H. Dumard, Francisca H. Guedes-da-Silva, Ana C. Vicente Santos, Monique dos Santos Leandro, Jesuino Rafael Machado Ferreira, Kamila Guimarães-Pinto, Luciana Conde, Danielle A. S. Rodrigues, Marcus Vinicius de Mattos Silva, Renata G. F. Alvim, Tulio M. Lima, Federico F. Marsili, Daniel P. B. Abreu, Orlando C. Ferreira Jr., Ronaldo da Silva Mohana Borges, Amilcar Tanuri, Thiago Moreno L. Souza, Bartira Rossi-Bergmann, André M. Vale, Jerson Lima Silva, Andréa Cheble de Oliveira, Alessandra D’Almeida Filardy, Andre M. O. Gomes, Herbert Leonel de Matos Guedes
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The SARS-CoV-2 pandemic has had a social and economic impact worldwide, and vaccination is an efficient strategy for diminishing those damages. New adjuvant formulations are required for the high vaccine demands, especially adjuvant formulations that
Externí odkaz:
https://doaj.org/article/d7351cdcf7ad400ca37a6f6c36710762
Autor:
Luan Firmino-Cruz, Júlio Souza dos-Santos, Alessandra Marcia da Fonseca-Martins, Diogo Oliveira-Maciel, Gustavo Guadagnini-Perez, Victor A. Roncaglia-Pereira, Carlos H. Dumard, Francisca H. Guedes-da-Silva, Ana C. Vicente Santos, Renata G. F. Alvim, Tulio M. Lima, Federico F. Marsili, Daniel P. B. Abreu, Bartira Rossi-Bergmann, Andre M. Vale, Alessandra D’Almeida Filardy, Jerson Lima Silva, Andrea Cheble de Oliveira, Andre M. O. Gomes, Herbert Leonel de Matos Guedes
Publikováno v:
Vaccines, Vol 10, Iss 8, p 1305 (2022)
Despite the intramuscular route being the most used vaccination strategy against SARS-CoV-2, the intradermal route has been studied around the globe as a strong candidate for immunization against SARS-CoV-2. Adjuvants have shown to be essential vacci
Externí odkaz:
https://doaj.org/article/71003c2cffe142ad96ce5b6c570e969f
Autor:
Diogo Oliveira-Maciel, Júlio Souza dos-Santos, Gabriel Oliveira-Silva, Mirian França de Mello, Alessandra Marcia da Fonseca-Martins, Monique Pacheco Duarte Carneiro, Tadeu Diniz Ramos, Luan Firmino-Cruz, Daniel Claudio Oliveira Gomes, Bartira Rossi-Bergmann, Herbert Leonel de Matos Guedes
Publikováno v:
Microorganisms, Vol 9, Iss 6, p 1272 (2021)
There is so far no vaccine approved for human leishmaniasis, mainly because of the lack of appropriate adjuvants. This study aimed to evaluate in mice the capacity of a mixture of monophosphoryl lipid A (MPLA) and AddaVax® adjuvants in enhancing the
Externí odkaz:
https://doaj.org/article/107c8e7ffa3d405d97e23d291dec8451
Autor:
Júlio Souza dos-Santos, Luan Firmino-Cruz, Tadeu Diniz Ramos, Alessandra Marcia da Fonseca-Martins, Diogo Oliveira-Maciel, Juliana Valente Rodrigues De-Medeiros, Suzana Passos Chaves, Daniel Claudio Oliveira Gomes, Herbert Leonel de Matos Guedes
Publikováno v:
Frontiers in Medicine, Vol 6 (2019)
Leishmaniasis is a complex of neglected diseases caused by parasites of the genus Leishmania, such as Leishmania (Leishmania) amazonensis, the ethiologic agent of diffuse cutaneous leishmaniasis in Brazil. In this work, we investigated a new experime
Externí odkaz:
https://doaj.org/article/84ceda1418974230aac4ca9d062b3f74
Autor:
Juliana Elena Silveira Pratti, Alessandra Marcia da Fonseca Martins, Juliana Paiva da Silva, Tadeu Diniz Ramos, Joyce Carvalho Pereira, Luan Firmino-Cruz, Diogo Oliveira-Maciel, Thiago Soares de Souza Vieira, Leandra Linhares Lacerda, Andre Macedo Vale, Celio G Freire-de-Lima, Daniel C Oliveira Gomes, Elvira M Saraiva, Bartira Rossi-Bergmann, Herbert Leonel de Matos Guedes
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 13, Iss 2, p e0007146 (2019)
Leishmania (L.) amazonensis is one of the etiological agents of cutaneous leishmaniasis (CL) in Brazil. Currently, there is no vaccine approved for human use against leishmaniasis, although several vaccine preparations are in experimental stages. One
Externí odkaz:
https://doaj.org/article/10d8b290717741db8d3be708f986a253
Autor:
Andréa C. Oliveira, Ronaldo Da Silva Mohana Borges, Francisca H. Guedes-da-Silva, Thiago Moreno L. Souza, Andre M. Vale, Kamila Guimarães-Pinto, Daniel Paiva Barros de Abreu, Gustavo Guadagini Perez, Diogo Oliveira-Maciel, Herbert Leonel de Matos Guedes, Jesuino Rafael Machado Ferreira, Marcus V. M. Silva, Federico F. Marsili, Danielle A. S. Rodrigues, Alessandra Marcia da Fonseca-Martins, Orlando C. Ferreira, Alessandra D’Almeida Filardy, Luan Firmino-Cruz, Jerson L. Silva, Tulio M. Lima, Victor A. R. Pereira, Monique dos Santos Leandro, Andre M. O. Gomes, Renata G. F. Alvim, Bartira Rossi-Bergamnn, Amilcar Tanuri, Carlos H. Dumard, Júlio Souza dos-Santos, Luciana Conde, Ana Clara Vicente dos Santos
The SARS-CoV-2 pandemic has had a social and economic impact worldwide, and vaccination is an efficient strategy for diminishing those damages. New adjuvant formulations are required for the high vaccine demands, especially adjuvant formulations that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73f5984d739cc7cff0649ae37f864611
https://doi.org/10.1101/2021.10.05.461434
https://doi.org/10.1101/2021.10.05.461434
Autor:
Tadeu Diniz Ramos, Mirian França de Mello, Bartira Rossi-Bergmann, Herbert Leonel de Matos Guedes, Monique Pacheco Duarte Carneiro, Júlio Souza dos-Santos, Luan Firmino-Cruz, Daniel Cláudio de Oliveira Gomes, Alessandra Marcia da Fonseca-Martins, Gabriel Oliveira-Silva, Diogo Oliveira-Maciel
Publikováno v:
Microorganisms
Volume 9
Issue 6
Microorganisms, Vol 9, Iss 1272, p 1272 (2021)
Volume 9
Issue 6
Microorganisms, Vol 9, Iss 1272, p 1272 (2021)
There is so far no vaccine approved for human leishmaniasis, mainly because of the lack of appropriate adjuvants. This study aimed to evaluate in mice the capacity of a mixture of monophosphoryl lipid A (MPLA) and AddaVax® adjuvants in enhancing the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e5ce26efb711533307f7beb64ca5b2f
https://pubmed.ncbi.nlm.nih.gov/34207948
https://pubmed.ncbi.nlm.nih.gov/34207948
Autor:
Herbert Leonel de Matos Guedes, Joyce Carvalho Pereira, Leandra Linhares Lacerda, Daniel Cláudio de Oliveira Gomes, Tadeu Diniz Ramos, Andre M. Vale, Alessandra Marcia da Fonseca Martins, Juliana Elena Silveira Pratti, Diogo Oliveira-Maciel, Luan Firmino-Cruz, Thiago Soares de Souza Vieira, Celio Geraldo Freire-de-Lima, Elvira M. Saraiva, Bartira Rossi-Bergmann, Juliana Paiva da Silva
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 13, Iss 2, p e0007146 (2019)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases
Leishmania (L.) amazonensis is one of the etiological agents of cutaneous leishmaniasis (CL) in Brazil. Currently, there is no vaccine approved for human use against leishmaniasis, although several vaccine preparations are in experimental stages. One
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4910b771e1a1fd2be95089078da8029
http://europepmc.org/articles/PMC6405171?pdf=render
http://europepmc.org/articles/PMC6405171?pdf=render
Autor:
Tadeu Diniz Ramos, Alexandre Morrot, Gabriel Oliveira-Silva, Herbert Leonel de Matos Guedes, Alessandra Marcia da Fonseca-Martins, Debora Decote-Ricardo, Júlio Souza dos Santos, Diogo Oliveira-Maciel, Celio Geraldo Freire-de-Lima, Andre M. Vale, Luan Firmino-Cruz, Cecilia B. Cavazzoni, Daniel Cláudio de Oliveira Gomes
Publikováno v:
Immunobiology. 225:151857
Over the years research has found an association between B lymphocytes and pathogenesis during Leishmania sp. infections. Recently we demonstrated that B-2 lymphocytes are the main producers of IL-10 during L. amazonensis infection, and that the dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a429e4583f40d0ff7fe4f4d87f6b809
https://doi.org/10.1016/j.imbio.2019.10.006
https://doi.org/10.1016/j.imbio.2019.10.006